Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae

Thumbnail Image

Download

2002 IJAA Calvo gemifloxacono Letter.pdf (91.04 KB)

Official URL

https://doi.org/10.1016/S0924-8579(02)00119-X

Full text at PDC

Publication date

2002

Authors

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier
Citations
Google Scholar
Exportar
DC QDC MarcXML RDF MODS METS ORE-ATOM

URI

https://hdl.handle.net/20.500.14352/107072

Citation

Calvo A, Giménez MJ, Alou L, Gómez-Lus ML, Aguilar L, Prieto J. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae. Int J Antimicrob Agents. 2002 Aug;20(2):144-6.

Abstract

Research Projects

Organizational Units

Journal Issue

Description

UCM subjects

Microbiología médica

Unesco subjects

2414 Microbiología

Keywords

Collections

Artículos